racecadotril has been researched along with naloxone in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (37.50) | 18.7374 |
| 1990's | 8 (50.00) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bokszanska, A; Brinkman, EC; Cappendijk, SL; Dzoljic, M; Dzoljic, MR; Kaplan, CD; Korenhof, AM; Rupreht, J; Zijlstra, FJ | 1 |
| Costentin, J; Dourmap, N; Michael-Titus, A; Schwartz, JC | 1 |
| Caline, H; Costentin, J; Dourmap, N; Michael-Titus, A; Schwartz, JC | 1 |
| Jivegård, L; Moreau, J; Pollard, H; Schwartz, JC; Svanvik, J; Thune, A | 1 |
| Costentin, J; Giros, B; Michael-Titus, A; Preterre, P | 1 |
| Livingston, SJ; Rooney, KF; Sewell, RD; Smith, HJ | 1 |
| Costentin, J; Lecomte, JM; Marçais-Collado, H; Schwartz, JC; Uchida, G | 1 |
| Chaillet, P; Costentin, J; Leboyer, M; Lecomte, JM; Llorens-Cortes, C; Marcais-Collado, H; Schwartz, JC; Vlaiculescu, A | 1 |
| Adjroud, O | 1 |
| Dumont, P; Lambert, DM; Mergen, F; Poupaert, JH | 1 |
| Benouali, S; Berard, H; Roche, M | 1 |
| Gray, AM; Sewell, RD; Spencer, PS | 1 |
| Bourin, M; Colombel, MC; Malinge, M; Vasar, E | 1 |
| Baumer, P; Berard, H; Bueno, L; Lecomte, JM; Primi, MP | 1 |
| Gross, GJ; Krylatov, AV; Lishmanov, IuB; Maslov, LN; Naryzhnaia, NV; Stephano, JB | 1 |
16 other study(ies) available for racecadotril and naloxone
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The effects of orally active enkephalinase inhibitors on morphine withdrawal syndrome.
Topics: Administration, Oral; Analgesics; Animals; Dioxolanes; Dipeptides; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Male; Mice; Morphine; Morphine Dependence; Naloxone; Neprilysin; Rats; Rats, Wistar; Stereotyped Behavior; Substance Withdrawal Syndrome; Thiorphan | 1992 |
Role of delta opioid receptors in the effects of inhibitors of enkephalin-degrading peptidases on the horizontal and vertical components of locomotion in mice.
Topics: Aminopeptidases; Animals; CD13 Antigens; Dipeptides; Drug Synergism; Enkephalin, Leucine; Enkephalins; Injections, Intravenous; Injections, Intraventricular; Leucine; Locomotion; Male; Mice; Naloxone; Neprilysin; Phenylcarbamates; Prodrugs; Receptors, Opioid; Receptors, Opioid, delta; Sulfhydryl Compounds; Thiorphan | 1990 |
Role of endogenous enkephalins in locomotion and nociception studied with peptidase inhibitors in two inbred strains of mice (C57BL/6J and DBA/2J).
Topics: Analgesics; Animals; Cerebral Ventricles; Enkephalins; Injections, Intraventricular; Leucine; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Motor Activity; Naloxone; Pain; Protease Inhibitors; Reference Values; Species Specificity; Thiorphan | 1989 |
Naloxone-reversible inhibition of gall-bladder mucosal fluid secretion in experimental cholecystitis in the cat by acetorphan, an enkephalinase inhibitor.
Topics: Animals; Bile; Cats; Cholecystitis; Gallbladder; Mucous Membrane; Naloxone; Neprilysin; Thiorphan | 1989 |
Role of endogenous enkephalins in locomotion evidenced by acetorphan, an "enkephalinase" inhibitor.
Topics: Amino Acids, Sulfur; Animals; Dose-Response Relationship, Drug; Enkephalins; Hydroxydopamines; Male; Metalloendopeptidases; Mice; Motor Activity; Naloxone; Neprilysin; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Thiorphan; Tiopronin | 1987 |
Amelioration of naloxone-precipitated opioid withdrawal symptoms by peripheral administration of the enkephalinase inhibitor acetorphan.
Topics: Amino Acids, Sulfur; Analgesics; Animals; Body Temperature; Body Weight; Male; Metalloendopeptidases; Mice; Mice, Inbred Strains; Morphine; Morphine Dependence; Naloxone; Neprilysin; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Thiorphan; Tiopronin | 1988 |
Naloxone-reversible antidiarrheal effects of enkephalinase inhibitors.
Topics: Amino Acids, Sulfur; Animals; Castor Oil; Diarrhea; Drug Interactions; Gastrointestinal Transit; Loperamide; Male; Metalloendopeptidases; Mice; Naloxone; Neprilysin; Rats; Rats, Inbred Strains; Thiorphan; Tiopronin | 1987 |
Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor.
Topics: Amino Acids, Sulfur; Analgesics; Animals; Antidiarrheals; Biogenic Amines; Brain Chemistry; Dose-Response Relationship, Drug; Endopeptidases; Enkephalin, Methionine; Injections; Kinetics; Male; Mice; Naloxone; Neprilysin; Protease Inhibitors; Rats; Rats, Inbred Strains; Thiorphan; Tiopronin | 1986 |
Peripheral excitatory effects of two enkephalinase inhibitors, acetorphan and thiorphan, and an enkephalin analogue, [D-Ala2-Met5]-enkephalinamide, on uterine motility in periparturient rats in vivo and in vitro.
Topics: Animals; Dose-Response Relationship, Drug; Enkephalin, Methionine; Female; Naloxone; Narcotic Antagonists; Neprilysin; Neurotransmitter Agents; Pregnancy; Protease Inhibitors; Rats; Rats, Wistar; Stimulation, Chemical; Thiorphan; Uterine Contraction | 1995 |
Analgesic potency of S-acetylthiorphan after intravenous administration to mice.
Topics: Analgesics; Animals; Injections, Intravenous; Male; Mice; Naloxone; Neprilysin; Pain Measurement; Thiorphan | 1993 |
Action of enkephalinase (EC 3.4.24.11) inhibition on the pre- and post-prandial electromyographic patterns of colon in rats.
Topics: Animals; Cecum; Colon; Eating; Electromyography; Endorphins; Gastrointestinal Motility; Male; Membrane Proteins; Naloxone; Neprilysin; Rats; Rats, Wistar; Receptors, Opioid; Thiorphan | 1993 |
The involvement of the opioidergic system in the antinociceptive mechanism of action of antidepressant compounds.
Topics: Abdominal Muscles; Acetic Acid; Amitriptyline; Analgesics; Animals; Antidepressive Agents; Cyclobutanes; Dothiepin; Male; Maprotiline; Mice; Muscle Contraction; Naloxone; Naltrexone; Narcotic Antagonists; Neprilysin; Neurotransmitter Uptake Inhibitors; Opioid Peptides; Pain Measurement; Paroxetine; Protease Inhibitors; Receptors, Opioid; Selective Serotonin Reuptake Inhibitors; Thiorphan | 1998 |
Cholecystokinin receptor agonists block the jumping behaviour precipitated in morphine-dependent mice by naloxone.
Topics: Animals; Ceruletide; Devazepide; Dose-Response Relationship, Drug; Hormone Antagonists; Male; Mice; Morphine Dependence; Motor Activity; Naloxone; Narcotic Antagonists; Pyrazoles; Receptors, Cholecystokinin; Substance Withdrawal Syndrome; Tetragastrin; Thiorphan | 1999 |
Racecadotril demonstrates intestinal antisecretory activity in vivo.
Topics: Animals; Antidiarrheals; Cholera Toxin; Dogs; Intestinal Mucosa; Naloxone; Neprilysin; Phentolamine; Protease Inhibitors; Thiorphan | 1999 |
[Role of delta opioid receptors and their ligands in the development of adaptive heart protection against arrhythmogenesis].
Topics: Adaptation, Physiological; Animals; Arrhythmias, Cardiac; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Leucine; Ligands; Male; Myocardial Reperfusion Injury; Naloxone; Naltrexone; Narcotic Antagonists; Oligopeptides; Rats; Rats, Wistar; Receptors, Opioid, delta; Tetrahydroisoquinolines; Thiorphan | 2001 |